BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen C, Shapiro R. New immunosuppressive agents in pediatric transplantation. Clinics (Sao Paulo) 2014;69 Suppl 1:8-16. [PMID: 24860853 DOI: 10.6061/clinics/2014(sup01)03] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sharma D, Sharma N. A potential drug in the armamentarium of post-cardiac transplantation immunosuppression: belatacept. Indian J Thorac Cardiovasc Surg 2020;36:625-8. [PMID: 33100623 DOI: 10.1007/s12055-020-00991-4] [Reference Citation Analysis]
2 Otarigho B. Structural, functional and docking analysis against Schistosoma mansoni dihydroorotate dehydrogenase for potential chemotherapeutic drugs. F1000Res 2019;8:651. [DOI: 10.12688/f1000research.18904.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Chen L, Peng Y, Ji C, Yuan M, Yin Q. Network pharmacology-based analysis of the role of tacrolimus in liver transplantation. Saudi J Biol Sci 2021;28:1569-75. [PMID: 33732042 DOI: 10.1016/j.sjbs.2020.12.050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kotb MA, Abd El Satar I, Badr AM, Anis NH, Abd El Rahman Ismail H, Hamza AF, Abdelkader HM. Pulmonary hypertension and cardiac hypertrophy in children recipients of orthotopic living related liver transplantation. J Adv Res 2017;8:663-8. [PMID: 28879059 DOI: 10.1016/j.jare.2017.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Yang Y, Yu B, Chen Y. Blood disorders typically associated with renal transplantation. Front Cell Dev Biol. 2015;3:18. [PMID: 25853131 DOI: 10.3389/fcell.2015.00018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
6 Azeka E, Jatene MB, Miura N, Fine R. Common challenge topics in pediatric transplantation. Clinics (Sao Paulo) 2014;69 Suppl 1:1-2. [PMID: 24860851 DOI: 10.6061/clinics/2014(sup01)01] [Reference Citation Analysis]
7 Zhang W, Egashira N, Masuda S. Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities. Int J Mol Sci 2019;20:E3210. [PMID: 31261959 DOI: 10.3390/ijms20133210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
8 Heble A, Everitt MD, Gralla J, Miyamoto SD, Lahart M, Eshelman J. Safety of mTOR inhibitor continuation in pediatric heart transplant recipients undergoing surgical procedures. Pediatr Transplant 2018;22. [PMID: 29210159 DOI: 10.1111/petr.13093] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]